Literature DB >> 14513279

[Endocrine tumors of the testis].

V Loy1, J Linke.   

Abstract

The most characteristic endocrine tumours of the testis are germ cell tumours and sex cord/gonadal stromal tumours. They include the primary carcinoid, the relation of which to teratomas is still unclear. In general, gonadal stromal tumours are rare, however, endocrine activity occurs in at least 10%-20%. Among gonadal stromal tumours, only Leydig cell tumours and Sertoli cell tumours are of practical importance. Endocrine disorders are mostly related to Leydig cell tumours (gynaecomastia, pubertas praecox). Although less frequent than the other gonadal stromal tumours, they can, in principle, occur. The large cell calcifying Sertoli cell tumour occurs in association with other complex disorders (i.e. Peutz-Jeghers syndrome). Valuable markers are: inhibin, calretinin, cytokeratin, melan-A, CD-99, Ki-67, androgen receptor and p53. As the conventional morphology and immunohistological markers frequently overlap, unclear cases should be referred to specialised centres.

Entities:  

Mesh:

Year:  2003        PMID: 14513279     DOI: 10.1007/s00292-003-0620-2

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  12 in total

1.  Leydig cell tumor of the testis: comparison of histopathological and immunohistochemical features of three azoospermic cases and one malignant case.

Authors:  M Hekimgil; B Altay; B D Yakut; S Soydan; C Ozyurt; R Killi
Journal:  Pathol Int       Date:  2001-10       Impact factor: 2.534

2.  Immunohistochemical study of testicular sex cord-stromal tumors, including staining with anti-inhibin antibody.

Authors:  W G McCluggage; J H Shanks; C Whiteside; P Maxwell; S S Banerjee; J D Biggart
Journal:  Am J Surg Pathol       Date:  1998-05       Impact factor: 6.394

Review 3.  Feminizing and non-feminizing Sertoli cell tumors.

Authors:  J L Gabrilove; E K Freiberg; E Leiter; G L Nicolis
Journal:  J Urol       Date:  1980-12       Impact factor: 7.450

4.  Congenital juvenile granulosa cell tumour of the testis: report of a case showing extensive degenerative changes.

Authors:  J K Chan; V S Chan; K L Mak
Journal:  Histopathology       Date:  1990-07       Impact factor: 5.087

5.  The new melanoma markers: MART-1 and Melan-A (the NIH experience)

Authors:  P A Fetsch; F M Marincola; A Abati
Journal:  Am J Surg Pathol       Date:  1999-05       Impact factor: 6.394

6.  Inhibin-alpha CD99, HEA125, PLAP, and chromogranin immunoreactivity in testicular neoplasms and the androgen insensitivity syndrome.

Authors:  F Kommoss; E Oliva; F Bittinger; C J Kirkpatrick; M B Amin; A K Bhan; R H Young; R E Scully
Journal:  Hum Pathol       Date:  2000-09       Impact factor: 3.466

Review 7.  Non-germ cell tumors of testis.

Authors:  J P Dilworth; G M Farrow; J E Oesterling
Journal:  Urology       Date:  1991-05       Impact factor: 2.649

8.  Malignant Sertoli cell tumors of the testis: a study of 13 examples of a neoplasm frequently misinterpreted as seminoma.

Authors:  John D Henley; Robert H Young; Thomas M Ulbright
Journal:  Am J Surg Pathol       Date:  2002-05       Impact factor: 6.394

9.  Calretinin: a valuable marker of normal and neoplastic Leydig cells of the testis.

Authors:  David Augusto; Emmanuelle Leteurtre; Alexandre De La Taille; Bernard Gosselin; Xavier Leroy
Journal:  Appl Immunohistochem Mol Morphol       Date:  2002-06

10.  Gonadal stromal tumors: a report of the Prepubertal Testicular Tumor Registry.

Authors:  G W Kaplan; W J Cromie; P P Kelalis; I Silber; E S Tank
Journal:  J Urol       Date:  1986-07       Impact factor: 7.450

View more
  1 in total

1.  Case report: primary carcinoid tumor of the testicle without metastases in combination with testicular atrophy and testosterone deficiency.

Authors:  Marco Wolf; Heiko Wunderlich; Winfried Hindermann; Mieczyslaw Gajda; Gerhard Schreiber; Jörg Schubert
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.